A vaccine formulated with the Chlamydia trachomatis (Ct) recombinant major outer membrane protein (rMOMP) and TLR2 and TLR9 agonists as adjuvants elicits strong protection against an intranasal challenge (166.4)
Year: 2012
Type: conference-abstract
Source: The Journal of Immunology
Institution: University of California, Irvine
Language: English
Subfield: Microbiology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W1586185899
